dulezidar/iStock via Getty Images Here we have yet another disappointing quarter for Tesla, Inc. ( TSLA ), with the company missing on Q1 revenue, guiding negative FCF for the rest of the year, delaying (again) the autonomy roadmap, and upgrading its CapEx guidance for 2026. By traditional standards, that combination should have crushed the stock. Yet, the stock is down in the low single digits as...
dulezidar/iStock via Getty Images Here we have yet another disappointing quarter for Tesla, Inc. ( TSLA ), with the company missing on Q1 revenue, guiding negative FCF for the rest of the year, delaying (again) the autonomy roadmap, and upgrading its CapEx guidance for 2026. By traditional standards, that combination should have crushed the stock. Yet, the stock is down in the low single digits as I'm writing this piece, largely as the broader markets are down due to the Hormuz disruption. This should make it clear to any bear on this stock that Tesla is not trading on current fundamentals alone. In fact, it's not trading either on its narrative, given that Optimus V3 wasn't officially unveiled in Q1 and the robotaxi deployment timeline was delayed once again. It is my view that a stock like Tesla is trading on liquidity and investor willingness to underwrite a future built around robotaxis and Optimus. Yes, that future may be so far away that the ticker TSLA may disappear by the time Optimus is replacing blue-collar jobs in factories. As many sources pointed out, SpaceX may be in talks to acquire Tesla, and I wouldn't be surprised, given their current partnership to build the largest chip fab ever. Back to my point. I am upgrading Tesla to a Strong Buy after the dire Q1 2026 results. Below, I provide my rationale. Revenue Miss, 2026 CapEx Upgrades, Negative FCF For the Year Yet despite the dire title above, the stock is down in the low single digits, proving once again that fundamentals and price action are still decoupled. Let's start with revenue. Q1 2026 revenue was $22.39 billion, below the $22.6 billion analyst consensus . Interestingly, it appears that analysts have recently cut expected 2026 delivery growth to about 3.8% from 8.2% in January. As you may remember, Q1 2026 deliveries came in at 358,023, missing the 368,903 consensus . Tesla Headlines like the one below should make it clear why the automotive business, which still accounts for over 70% of total...
dulezidar/iStock via Getty Images Here we have yet another disappointing quarter for Tesla, Inc. ( TSLA ), with the company missing on Q1 revenue, guiding negative FCF for the rest of the year, delaying (again) the autonomy roadmap, and upgrading its CapEx guidance for 2026. By traditional standards, that combination should have crushed the stock. Yet, the stock is down in the low single digits as...
dulezidar/iStock via Getty Images Here we have yet another disappointing quarter for Tesla, Inc. ( TSLA ), with the company missing on Q1 revenue, guiding negative FCF for the rest of the year, delaying (again) the autonomy roadmap, and upgrading its CapEx guidance for 2026. By traditional standards, that combination should have crushed the stock. Yet, the stock is down in the low single digits as I'm writing this piece, largely as the broader markets are down due to the Hormuz disruption. This should make it clear to any bear on this stock that Tesla is not trading on current fundamentals alone. In fact, it's not trading either on its narrative, given that Optimus V3 wasn't officially unveiled in Q1 and the robotaxi deployment timeline was delayed once again. It is my view that a stock like Tesla is trading on liquidity and investor willingness to underwrite a future built around robotaxis and Optimus. Yes, that future may be so far away that the ticker TSLA may disappear by the time Optimus is replacing blue-collar jobs in factories. As many sources pointed out, SpaceX may be in talks to acquire Tesla, and I wouldn't be surprised, given their current partnership to build the largest chip fab ever. Back to my point. I am upgrading Tesla to a Strong Buy after the dire Q1 2026 results. Below, I provide my rationale. Revenue Miss, 2026 CapEx Upgrades, Negative FCF For the Year Yet despite the dire title above, the stock is down in the low single digits, proving once again that fundamentals and price action are still decoupled. Let's start with revenue. Q1 2026 revenue was $22.39 billion, below the $22.6 billion analyst consensus . Interestingly, it appears that analysts have recently cut expected 2026 delivery growth to about 3.8% from 8.2% in January. As you may remember, Q1 2026 deliveries came in at 358,023, missing the 368,903 consensus . Tesla Headlines like the one below should make it clear why the automotive business, which still accounts for over 70% of total...
Here are Thursday’s top Wall Street analyst research calls: Boston Scientific, Datadog, Deckers Outdoor, McDonald’s, Murphy USA, On Semiconductor, Palantir Technologies, Texas Instruments, and more MSN
Here are Thursday’s top Wall Street analyst research calls: Boston Scientific, Datadog, Deckers Outdoor, McDonald’s, Murphy USA, On Semiconductor, Palantir Technologies, Texas Instruments, and more MSN
ConnectOne Bancorp ( CNOB ) declares $0.195/share quarterly dividend , 8.3% increase from prior dividend of $0.180. Forward yield 2.78% Payable June 1; for shareholders of record May 15; ex-div May 15. See CNOB Dividend Scorecard, Yield Chart, & Dividend Growth. More on ConnectOne Bancorp ConnectOne: Margin Improvement Provides Further Upside ConnectOne Bancorp, Inc. (CNOB) Q4 2025 Earnings Call T...
ConnectOne Bancorp ( CNOB ) declares $0.195/share quarterly dividend , 8.3% increase from prior dividend of $0.180. Forward yield 2.78% Payable June 1; for shareholders of record May 15; ex-div May 15. See CNOB Dividend Scorecard, Yield Chart, & Dividend Growth. More on ConnectOne Bancorp ConnectOne: Margin Improvement Provides Further Upside ConnectOne Bancorp, Inc. (CNOB) Q4 2025 Earnings Call Transcript ConnectOne outlines 2026 NIM growth and branch consolidation plans amid $14B asset milestone Seeking Alpha’s Quant Rating on ConnectOne Bancorp Historical earnings data for ConnectOne Bancorp
Ridgeline Minerals ( RDG:CA ) on Thursday reported 2026 budget guidance of $9.50M in partner-funded exploration between the Selena and Swift projects. The Selena project is a silver-lead-zinc-gold-copper carbonate replacement-style exploration project operated by Ridgeline Minerals and funded by a wholly owned subsidiary of South32. The project is currently operating under Phase I of an exploratio...
Ridgeline Minerals ( RDG:CA ) on Thursday reported 2026 budget guidance of $9.50M in partner-funded exploration between the Selena and Swift projects. The Selena project is a silver-lead-zinc-gold-copper carbonate replacement-style exploration project operated by Ridgeline Minerals and funded by a wholly owned subsidiary of South32. The project is currently operating under Phase I of an exploration earn-in agreement totaling up to $10M in qualifying expenditures over a 5-year period. South32 has approved a Year-3 work program and budget of $4.40M that, once funded and executed, is expected to satisfy Phase I of the exploration earn-in agreement. The Swift project is a Carlin-type gold exploration project being operated by Nevada Gold Mines under Phase I of an exploration earn-in agreement totaling up to $20M in NGM expenditures over a 5-year period. NGM has approved a 2026 exploration budget of $5.50M for a projected total of $20M in qualifying expenditures, which will satisfy Phase I of the exploration earn-in agreement. B -0.74% premarket to $40.43. Source: Press Release More on Barrick Mining Corporation, Ridgeline Minerals Corp., etc. TMX Group Limited (X:CA) M&A Call Transcript Barrick's North America IPO Is The Catalyst I Was Waiting For Barrick Mining: IPO Spinoff Dream Hits Royalty Shocker And Margin Squeeze Argo Graphene Solutions plans C$500,000 private placement Pineapple Financial expands share buyback program to $15M
Ladder Capital ( LADR ) stock gained after the commercial mortgage REIT delivered first-quarter earnings in line with expectations on robust loan origination activity. Shares were up 0.20% Thursday pre-market to $10.27. Distributable earnings per share of $0.22 was in line with the average analyst estimate of $0.22 and up from $0.20 recorded in the first quarter of 2025. The New York City-based co...
Ladder Capital ( LADR ) stock gained after the commercial mortgage REIT delivered first-quarter earnings in line with expectations on robust loan origination activity. Shares were up 0.20% Thursday pre-market to $10.27. Distributable earnings per share of $0.22 was in line with the average analyst estimate of $0.22 and up from $0.20 recorded in the first quarter of 2025. The New York City-based company reported GAAP income before taxes of $0.02 per share, below the consensus of $0.09. GAAP book value per share came in at $11.33, down from the average analyst estimate of $11.45. Net interest income came in at $23.0M during the quarter, up from $20.3M during the first quarter of 2025 but below the consensus of $24.0M. Real estate operating income stood at $27.3M, while fee and other income was recorded at $1.4M. "During the first quarter, we produced our highest quarterly loan origination volume in four years, as we continue to see attractive opportunities," said CEO Brian Harris. "With a strong asset base, robust liquidity, and access to investment-grade capital markets, we are well-positioned to continue growing our balance sheet and earnings," said Harris. The company originated $621M of new loans during the first quarter, with $372M of loans originated in the second quarter already. The board authorized a $100M class A share repurchase program on April 21. An earnings conference call is scheduled for 10:00 AM ET. More on Ladder Capital Ladder Capital: Don't Worry About The Dividend Shortfall Ladder Capital: No Harm In Positioning Itself Conservatively Ladder Capital Corp 2025 Q4 - Results - Earnings Call Presentation Ladder Capital Q1 2026 Earnings Preview Ladder Capital signals over $6B loan portfolio growth by year-end 2026 as payoffs slow and origination ramps up
Niteenrk/iStock via Getty Images Intro Our last commentary on Ternium S.A . ( TX ) was in September 2022, when we placed a 'Sell' rating on the steel manufacturer when shares were trading just below $30 a share. Shares did, in fact, drop from that point to close to the $27 mark in the following month, but have since rebounded aggressively to presently trade above $40 a share over three years later...
Niteenrk/iStock via Getty Images Intro Our last commentary on Ternium S.A . ( TX ) was in September 2022, when we placed a 'Sell' rating on the steel manufacturer when shares were trading just below $30 a share. Shares did, in fact, drop from that point to close to the $27 mark in the following month, but have since rebounded aggressively to presently trade above $40 a share over three years later. We are covering Ternium again as we approach the release of the company's first-quarter earnings for FY26, due on the 5th of May next. First, though, a few words on where Ternium resources are aligned in the steel industry and where, in particular, it demonstrates strength relative to the competition at this very moment. The Luxembourg-based outfit principally operates internationally in both the steel and mining sectors. For example, Mexico is a significant hub for the company, where the Pesqueria location is in an expansion phase. In Brazil and neighbouring Latin American countries, Ternium's flat steel positioning remains prominent, with multiple industries being serviced throughout the region. Astuteness concerning investments with respect to the company's strong production capacity, along with its integrated supply chain (facilitating synergies, leading to lower costs), has positioned Ternium well in the markets it operates in. The company recently received an upgrade from Bank of America on expected rising US flat steel prices, but this came on the back of a downgrade by Scotiabank in March this year, citing the USMCA agreement and persistent US steel tariffs as roadblocks to sustained upside in the stock. Suffice it to say, there are a lot of moving parts in Ternium, but investors need to remember that the Steel industry is cyclical and can change on a dime in what could be perceived to be an industry projected to grow aggressively going forward. What we are pointing out here is that Ternium is expected to grow its earnings by 3%+ and 30%+ (EPS of $4.75 - current i...
Pot Stocks Soar As DoJ Reclassifies Medical Marijuana As Less Dangerous Drug Pot stocks are moving higher in premarket trading in New York after the Justice Department and DEA announced that FDA-approved marijuana-based drugs and state-licensed medical marijuana products will be moved immediately from Schedule I to Schedule III. This is a major shift in how the federal government classifies these ...
Pot Stocks Soar As DoJ Reclassifies Medical Marijuana As Less Dangerous Drug Pot stocks are moving higher in premarket trading in New York after the Justice Department and DEA announced that FDA-approved marijuana-based drugs and state-licensed medical marijuana products will be moved immediately from Schedule I to Schedule III. This is a major shift in how the federal government classifies these types of cannabis products. *DOJ RECLASSIFIES MEDICAL MARIJUANA AS A LESS-DANGEROUS DRUG: AP — zerohedge (@zerohedge) April 23, 2026 The classification is designed to expand access to approved therapies, support state-regulated medical marijuana programs, and make research easier, while still keeping federal controls in place against black market operators. The reclassification legitimizes medical marijuana programs already operating in 40 states. It also creates a faster DEA registration path for state-licensed medical marijuana operators and protects researchers using state-licensed cannabis products. "The Department of Justice is delivering on President Trump’s promise to expand Americans’ access to medical treatment options," Acting Attorney General Todd Blanche stated in a press release. Blanche continued, “This rescheduling action allows for research on the safety and efficacy of this substance, ultimately providing patients with better care and doctors with more reliable information.” It appears the Trump administration is taking a two-track approach: immediate relief and policy clarity for medical marijuana and researchers, while also setting up a faster legal roadmap toward broader federal reclassification later. The news sent marijuana stocks soaring in premarket trading: Canopy Growth (CGC): $1.48, up about 7% Tilray Brands (TLRY): $8.50, up about 8% Aurora Cannabis (ACB): $4.01, up about 5.5% Cronos Group (CRON): $3, up about 7% Organigram Global (OGI): $1.67, up about 5% SNDL (SNDL): $1.77, up about 6.6% Village Farms (VFF): $3.31, up about 7% Amplify Alternati...
Alison Calazans/iStock Editorial via Getty Images Franklin FTSE Latin America Overview Latin American equities have broken out recently following years of underperforming emerging markets. It appears that momentum should continue in 2026 since these markets are reasonably valued and offer exposure to commodities. Data by YCharts The Franklin FTSE Latin America ETF ( FLLA ) has had favorable perfor...
Alison Calazans/iStock Editorial via Getty Images Franklin FTSE Latin America Overview Latin American equities have broken out recently following years of underperforming emerging markets. It appears that momentum should continue in 2026 since these markets are reasonably valued and offer exposure to commodities. Data by YCharts The Franklin FTSE Latin America ETF ( FLLA ) has had favorable performance since its inception and has outperformed its regional peer, the iShares Latin America 40 ETF ( ILF ). FLLA offers more unique exposure to the market since it has nearly 100 more company holdings, but its country and sector approach is similar to that of ILF. Overall, I think that FLLA is a better way to access Latin America's stock market. Latin America has a series of unique catalysts, including its commodity export growth and supply of key critical minerals. At the moment, these growth drivers should help offset some of the broader macro risks approaching, including a potential rebound of inflation as seen in 2022. FLLA should continue to slightly outperform emerging markets in 2026 and 2027, and looks like a stable hold at the moment. For investors who want to dig deeper, it would be better to invest directly in a basket of country-specific ETFs to increase exposure to Chile and Colombia. Franklin FTSE Latin America ETF Overview The Franklin FTSE Latin America ETF is a smaller ETF ($89 million AUM) that invests in 138 companies in Latin America, primarily in Brazil. It only charges a 0.19% management fee, compared to the 0.47% management fee charged by the iShares Latin America 40 ETF. At the moment, FLLA trades at a circa 24% discount to MSCI Emerging Markets on a price to earnings basis. Franklin Templeton The majority of the companies it covers include mid-cap and large-cap stocks with a market cap above $10 billion. Franklin Templeton This approach has been a superior way to access the market since 2020, as displayed by the divergence in performance between Bra...